Ideas that aren’t just “buy gold”
About this video
Key Highlights:
Discusses global market fluctuations in response to Jerome Powell's Jackson Hole speech
Highlights the ongoing shift from large-cap to small-cap stocks amidst falling rates
Emphasizes the potential of the cannabis industry in collaboration with 'Chemist Warehouse' and 'One Life Botanicals'
James Whelan of Barclay Pearce Capital shares his views on the global markets' reaction to Jerome Powell's speech at the Jackson Hole symposium. He thinks the market expected a dovish stance and was satisfied with what was delivered. James provides insight into the disparity between the bond market and the Fed's actions. He hints at a 50 basis point cut and explores the possible market reactions, with the focus on whether or not there will be a recession in the US within the next 12 months.
Looking at the equity market, James discusses the dramatic sell-off three weeks ago. Evidence suggests that the Bank of Japan might investigate another hike, but he also warns of pitfalls from rotation into small caps out of The Magnificent Seven. As he suggests, with rates dropping and no signs of an imminent recession in the US economy, small caps could be back on the market's agenda.
The conversation then shifts towards commodity and niche markets. James expresses his enduring preference for gold, citing its dependability amidst fluctuating rates and global uncertainties. He also investigates the potential of the cannabis industry. After visiting a unique facility in Victoria, he mentions an upcoming collaboration between 'One Life Botanicals' and 'Chemist Warehouse', a company which currently represents 20% of Australia's national pharmaceutical prescription market but only 1% of its medicinal cannabis market. James sees huge potential in this collaboration and the cannabis industry overall.
Full unedited transcript:
0:00
Let's get across what we're seeing in global markets at the moment, particularly in the wake of that Jackson Hole symposium. James Whalen joining us from Berkeley Capital. James, welcome. Of course, all eyes were on or ears. We're listening intently to Jerome Powell on Friday. And look he delivered didn't he really. That's what markets wanted to hear. You throw him an underarm and he put it over the fence. It was sensational. I was saying that the only way that could have been more market friendly is if they'd literally released doves while he was speaking as well, but he couldn't. It couldn't have been more dovish, could it? But what's the telling is okay, so we know the cuts coming in September at the time just come. How big are they going to go? I don't think there's going to be a 50. However, it's a weird thing because you've got the bond market that's pricing in the certain number of of of cuts that need to happen. And then you've got the fed that's actually just said, no, we're just going to be doing this. There's a bit of a bit of a disparity between the two. I'm not entirely sure when the 50 comes, although if it comes to the bond market, listen, listen ahead to them. But see, we've had the attention was really taken
0:59
up. If we sort of sort of go back over the last few weeks of exactly what we've had taking up the headlines, we had, what, a couple of weeks ago, Bank of Japan, The Great Unwind that carry trade that caused ripples through everything. Some new way of measuring if a recession is coming in the US was, was was talked about and and and that was sort of put a lot of fear into the market for a while. And then we've had uh, and then we've, and then we've, and then we've had Jackson Hole, which has taken up all of the attention again, what we've got now, I'll just get straight into it. Beware, beware and beware those people who come out and say that, ah, when the fed starts cutting, that always correlates with the market correcting. They'll say that. And if you take every single one, then technically it's sort of half does. However, if you really break it down now, yes, only five in in one side and only three examples on the other side. However, it's the same. If the fed starts cutting and there's a recession, then the market will usually come down. On average, it'll come down by about that 15% mark. This is the S&P 500. If there is no recession in the fed starts cutting, then the market goes
1:59
up. Now, if you think that there's going to be a recession in the next 12 months in the US, then you're going to have a bit of a bad time. But if you don't. So we don't we don't you don't know what the future actually holds on this case. However, if they were going to go 50 basis points, would the market have a bit of a conniption? They're saying, whoa, okay. Clearly the fed thinks the economy is worse than than they have been. You would think you would have to think that the narrative would very much be on. Why are they doing 50? Because a 50 would be the result of some really cataclysmic data that would come out. Remember, they're still data driven. They're still looking at this. They're not completely blind. Is there something that comes out that that shows that an absolute, um, that also that the food is back on the back on the accelerator pedal in a massive way? Then they might actually be held off on a September thing. That's not a it's not a done, 100% done deal. He says that it is actually but it's not you know what I mean? But it is. But it's not so. James, what are your observations then, what you've seen with the equity market, in fact, might get the chart up here, uh, just as to where we've been at because, um, what was it three weeks ago now? You had that dramatic sell off. Yep.
3:00
Remember? And it was blood in the streets. It's all going over. There was a circuit breakers in Japan. Yeah, everything went absolutely bananas. And there was a very simple thing just looking at. Calm your head. It's the Ned Davis research. Uh, people or the NDR, their trading sentiment composite was at its lowest level since since late 2022. And as they always say, when short term sentiment is this washed out stocks usually rip dip buyers at that particular point because, you know, fast forward three weeks, it's as though it never happened. It is just straight an eradication of everything that happened. Are those problems still there? Well, it looks like I saw something over the weekend that the Bank of Japan might be looking at another hike. They still need to do something about their inflation problem. They can't just stop because they didn't want to get a market. They still have to find some way, find some way through that. However, I think it's just that unwind of that carry trade which everyone has just had to go, and then the forced liquidation of a lot of people that needed to be in that too. Retail panic selling that retail always entails it does. And the transfer of wealth to the institutional side. As
4:00
always, it goes on in that sort of way, the panicky hands and the flaky hands and the margin hands, the leveraged hands, they all had to had to quit that market. And that's sort of what caused a lot of that sell off. Well, and of course, prior to that, that rotation in the small caps was underway. Don't forget what we were doing. Cast your minds back to that beautiful time. July 2024. People were friendlier. It was, you know, more joyful in the streets wasn't a beautiful time. But if you remember what was happening before Jackson Hole and before the Bank of Japan took up all the headlines, there was a rotation going on into the small caps out of The Magnificent Seven. Now, it wasn't a huge rotation out of out of this particular situations, but what it was a small exit out of those big stocks was actually megaphone into a huge small cap area. So it's just like, what? Now you've got the same circumstances, you've got rates coming off, you've got no recession hitting in the US economy. Why shouldn't small caps be back on the agenda again to go into it? Yes. You should still hold your magnificent seven. You shouldn't. So I've looked at. Look, if there's if there's a way. You guys always want to know. A way to be able to access these things. Vanek, always do some good
5:00
work. They've got their small caps ETF. Um, and this is a quality ETF. Holds about 150 global small caps, about 80% in the US. I've drawn a very, you know, a very rudimentary support line under that which is difficult to do with ETFs. But
5:16
it's close enough. It's good enough on these sort of bits and pieces. You know, you sort of got to squint and you want it and you should and you're going to get there. Small cap rotation. No reason why that can't happen. The US is not heading to a recession. As we can see right now. Rates are coming off go nuts. Okay, so you're looking to buy in that space. You're still buying gold. Of course. Yeah I I've been long I've been long. And talking about being long gold now for the, for as long as you can. That's the easiest play that there is. Yeah. One for an okay reason because rates are coming off and one for another not so okay reason which is what's going on
5:44
in the world. Right. We won't go into that. But it's, uh, gold. Gold is just being a great play. And also, yes, the inflation thing and all that sort of going on. So James, speaking of small caps or maybe let's go micro caps, even hyper micro caps. Cannabis. I was on the road last week. My friend and I went to Wanganui. Wonthaggi almost got it right. Wonthaggi regional, Victoria. So I went out there cannabis and I saw a cannabis facility first in class. I wasn't expecting it in regional Victoria, an amazing facility. They are the only place in the southern hemisphere. It's called One Life Botanicals. G'day. If they're watching. They took us out and showed us around the only place in the southern hemisphere that can do the gel caps with the cannabis in the gel caps, which you need to be an advanced facility to be able to do. Shut down. Beautiful thing. Joint venture between wellness them and Chemist Warehouse. Now here's the flag on the space. Cannabis has had had a run a while ago. Everyone had a cannabis stock. Tried and failed. A lot of these ones, a lot of shot down over the parapet so that maybe potentially someone like Chemist Warehouse can walk comfortably
6:44
across the battlefield. Excuse the metaphor. Um, chemist warehouse owned a chunk of this joint venture as well that these guys are producing. Um, they have a Chemist Warehouse, has 20% of the national pharmaceutical prescription market, 20% of the national prescription market. But in cannabis, in medicinal cannabis, they've only got 1%. That's a gap that Chemist Warehouse see. And and they want to try and close that gap. So keep your eye on cannabis at the moment because Chemist Warehouse sees a hole there and they need to fill it. And that's that's what they do. And when they get their mind down to something, I've never seen them fail before. Well, how high can you can you get. Can you go? It's it is, it is actually I'll tell you what the opioid crisis that there is going on in the world, cannabis solves a big chunk of that, of that crisis that's going on. I've really I've really started to embrace it as someone who's looking at it, not looking at it. You know, the jokes are easy and that's fine. It's good. But if you actually look at it as patients needing care and patients needing a prescription and going through it with the doctor and having something that's pretty well tailored to exactly what what is ailing you. This we could be back on
7:44
the back on the agenda of being able to solve a lot of the world's problems.